The Max Planck Insitute for Infection Biology is sharing news of interest to the Immunology Community.
Therapy with VPM1002 is effective in bladder cancer patients
The human immune system can recognize and eliminate not only germs but also cancer cells. This is why treatments with weakened germs can help the immune system it ist fight against cancer.
The Max Planck Insitute for Infection Biology has developed a vaccine against TB which is currently in phase III trial. Less known is that this vaccine is also tested for treatment of bladder cancer and it has now shown a remarkable outcome in a clinical trial in preventing cancer recurrence.
clinical trial no.: NCT02371447 (https://clinicaltrials.gov/ct2/show/NCT02371447)